This clinical reference provides the evidence to support the over-the-counter (OTC) medications time tool medications time tool from the Americal College of Preventive Medicine.

Age related macular degeneration (AMD) accounts for almost 50% of those registered as blind or partially sighted. 1-4 The development of management strategies is limited by the diverse nature of the age related changes and a lack of a clear understanding of the process of visual loss in the elderly. Effective treatment is limited to the management of sub-retinal neovascularisation (SRNV) in selected cases). Despite early expectations that laser treatment might provide significant benefit in preventing blindness 5-7 recurrent disease and progressive visual failure limit the final outcome. 8-9. Early recognition and prevention of potential disease is not as yet applicable to disease other than that related to SRNV. 

This Optometric Clinical Practice Guideline for Care of the Patient with Visual Impairment describes appropriate examination and treatment procedures for the evaluation of the visual abilities and eye health of people with visual impairments.  It contains recommendations for timely diagnosis, management, and, when needed, referral for consultation with (or treatment by) another health care provider or rehabilitation professional.

This guide has been commissioned by the International Society for Clinical Electrophysiology of Vision (ISCEV), to assist practitioners and administrators. It describes the principles of conducting a practice devoted to the diagnosis and management of patients with various visual disturbances. The need for such a guide has become apparent because the advances in this field have made it the subject of growing and more widespread importance.

The Canadian Guideline is presented in two separate documents: Part A (Executive Summary and Background) and Part B (Recommendations for Practice).  PDF versions posted on this website are the official Canadian Guideline documents. Web formatted content is the unofficial version of the Guideline. While best efforts have been made to ensure accuracy and consistency with the official documents, if any discrepancies exist in the web format, content of the PDF version shall apply. 

Authors: 
Institute for Safe Medication Practices Canada
 

The Institute for Safe Medication Practices (ISMP) Canada focuses on the advancement of safety with medication. It is in collaboration with healthcare groups, agencies and movers/shakers provincially, and internationally to make known information to make better practices where medications are being used, delievered.  They not only report but prevent situations of harmful disasters and encourage steps towardds quality improvement with initiatives. 

Photo de Le Guide

Une fois votre plan d’action adopté, suivez vos progrès tout au long de la mise en œuvre. L’évaluation de votre projet est une phase importante de l’établissement d’une CAA : elle éclairera les mesures futures et s’intégrera à un processus d’amélioration continue. Les indicateurs présentés dans votre plan d’action seront utiles pour la mesure de vos progrès.

 

Photo de Le Guide

Votre plan d’action vous servira de carnet de route pour guider les stratégies de planification de votre collectivité-amie des aînés. Servez-vous des résultats de l’analyse des besoins pour concevoir votre plan d’action. Vous tiendrez ainsi compte de vos priorités et cernerez des stratégies concrètes. Ce document distinct guidera la mise en œuvre et l’évaluation des activités CAA en précisant les échéanciers et les rôles de chacun.

Photo de Le Guide

Une évaluation des besoins permet de cerner les écarts entre, d’une part, les milieux bâti et social dans votre collectivité et, d’autre part, les besoins et aptitudes des personnes vivant dans votre collectivité.

Pages